Cargando…

Reusing a prepaid health plan’s fecal immunochemical tests for microbiome associations with colorectal adenoma

An altered colonic microbiota probably increases colorectal adenoma (CRA) and cancer (CRC) risk, but large, unbiased fecal collections are needed to examine the relationship of gut microbiota diversity and composition to colorectal carcinogenesis. This study assessed whether fecal immunochemical tes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goedert, James J., Wu, Zhenyi, Yonehara, Cyndee H., Frankland, Timothy B., Sinha, Rashmi, Jones, Gieira S., Wan, Yunhu, Ravel, Jacques, Zhao, Ni, Honda, Stacey A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433441/ https://www.ncbi.nlm.nih.gov/pubmed/36045142 http://dx.doi.org/10.1038/s41598-022-18870-w

Ejemplares similares

Improving Adenoma Detection Rates: The Role of the Fecal Immunochemical Test
por: Nwankwo, Eugene C, et al.
Publicado: (2021)

Prepaid parameter estimation without likelihoods
por: Mestdagh, Merijn, et al.
Publicado: (2019)

Leveraging Fecal Microbial Markers to Improve the Diagnostic Accuracy of the Fecal Immunochemical Test for Advanced Colorectal Adenoma
por: Zhang, Yuhan, et al.
Publicado: (2021)

Postmenopausal breast cancer and oestrogen associations with the IgA-coated and IgA-noncoated faecal microbiota
por: Goedert, James J, et al.
Publicado: (2018)

Mammographic breast density and its association with urinary estrogens and the fecal microbiota in postmenopausal women
por: Jones, Gieira S., et al.
Publicado: (2019)

Fecal Microbiota Characteristics of Patients with Colorectal Adenoma Detected by Screening: A Population-based Study
por: Goedert, James J., et al.
Publicado: (2015)

Fecal DNA Testing of TWIST1 Methylation Identifies Patients With Advanced Colorectal Adenoma Missed by Fecal Immunochemical Test for Hemoglobin
por: Suehiro, Yutaka, et al.
Publicado: (2020)

Positive Fecal Immunochemical Test Strongly Predicts Adenomas in Younger Adults With Fatty Liver and Metabolic Syndrome
por: Yeh, Jen-Hao, et al.
Publicado: (2021)

Feasibility of self-collection of fecal specimens by randomly sampled women for health-related studies of the gut microbiome
por: Feigelson, Heather Spencer, et al.
Publicado: (2014)

Immunochemical Fecal Occult Blood Test for Detection of Advanced Colonic Adenomas and Colorectal Cancer: Comparison with Colonoscopy Results
por: Viana Freitas, Bianca Rosa, et al.
Publicado: (2013)

Fecal Immunochemical Tests Detect Screening Participants with Multiple Advanced Adenomas Better than T1 Colorectal Cancers
por: Gies, Anton, et al.
Publicado: (2021)

Correction to: Positive Fecal Immunochemical Test Strongly Predicts Adenomas in Younger Adults With Fatty Liver and Metabolic Syndrome
por: Yeh, Jen-Hao, et al.
Publicado: (2021)

Expenditures for Mental Health Services in the Utah Prepaid Mental Health Plan
por: Stoner, Tamara, et al.
Publicado: (1997)

The Performance of Three-Sample Qualitative Immunochemical Fecal Test to Detect Colorectal Adenoma and Cancer in Gastrointestinal Outpatients: An Observational Study
por: Wu, Dong, et al.
Publicado: (2014)

Fecal Immunochemical Tests Combined With Other Stool Tests for Colorectal Cancer and Advanced Adenoma Detection: A Systematic Review
por: Niedermaier, Tobias, et al.
Publicado: (2016)

Determinants of prepaid systems of healthcare financing: a worldwide country-level perspective
por: Leiter, Andrea M., et al.
Publicado: (2021)

Using fecal immunochemical tubes for the analysis of the gut microbiome has the potential to improve colorectal cancer screening
por: Krigul, Kertu Liis, et al.
Publicado: (2021)

Microbiome Profiling from Fecal Immunochemical Test Reveals Microbial Signatures with Potential for Colorectal Cancer Screening
por: Khannous-Lleiffe, Olfat, et al.
Publicado: (2022)

Usefulness of fecal immunochemical test and fecal calprotectin for detection of active ulcerative colitis
por: Kim, Dong Ju, et al.
Publicado: (2018)

Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations
por: Sinha, Rashmi, et al.
Publicado: (2016)

Association of Fecal Microbial Diversity and Taxonomy with Selected Enzymatic Functions
por: Flores, Roberto, et al.
Publicado: (2012)

Which Fecal Immunochemical Test Should I Choose?
por: Daly, Jeanette M., et al.
Publicado: (2017)

Profiling small RNAs in fecal immunochemical tests: is it possible?
por: Birkeland, Einar, et al.
Publicado: (2023)

Divergent detection rates of fecal immunochemical test and questionnaire-based risk assessment for detecting proximal and distal advanced colorectal adenomas
por: Chen, Hong-Da, et al.
Publicado: (2021)

Risks and rewards of using prepaid vs. postpaid incentive checks on a survey of physicians
por: Wiant, Kristine, et al.
Publicado: (2018)

The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design
por: Wisse, P. H. A., et al.
Publicado: (2022)

Accuracy of H. pylori fecal antigen test using fecal immunochemical test (FIT)
por: Nieuwenburg, S. A. V., et al.
Publicado: (2021)

Fecal microbial determinants of fecal and systemic estrogens and estrogen metabolites: a cross-sectional study
por: Flores, Roberto, et al.
Publicado: (2012)

A73 EFFECT OF FECAL IMMUNOCHEMICAL TEST CUT-OFF LEVELS ON ADENOMA DETECTION RATE: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Zarandi-Nowroozi, M, et al.
Publicado: (2023)

Assessment of disease activity by fecal immunochemical test in ulcerative colitis
por: Ryu, Dae Gon, et al.
Publicado: (2016)

Are Hemorrhoids Associated with False-Positive Fecal Immunochemical Test Results?
por: Kim, Nam Hee, et al.
Publicado: (2017)

Screening for Colorectal Cancer by Immunochemical Fecal Occult Blood Testing
por: Saito, Hiroshi
Publicado: (1996)

Who chooses prepaid dental care? A baseline report of a prospective observational study
por: Andås, Charlotte Andrén, et al.
Publicado: (2014)

Fecal immunochemical test as a biomarker for inflammatory bowel diseases: can it rival fecal calprotectin?
por: Kato, Jun, et al.
Publicado: (2016)

Fecal Immunochemical Tests for Colorectal Cancer Screening: Is Fecal Sampling from Multiple Sites Necessary?
por: Amitay, Efrat L., et al.
Publicado: (2019)

Clinical implications of fecal calprotectin and fecal immunochemical test on mucosal status in patients with ulcerative colitis
por: Ryu, Dae Gon, et al.
Publicado: (2019)

Preference and Experience of Colonic Examination for Participants Presenting to Hospitals with a Positive Fecal Immunochemical Test Result
por: Kato, Takashi, et al.
Publicado: (2020)

Patients and Providers Are Amenable to Fecal Immunochemical Testing by Digital Rectal Exam
por: Naidu, Harini, et al.
Publicado: (2018)

Predicting the risk for colorectal cancer with personal characteristics and fecal immunochemical test
por: Li, Wen, et al.
Publicado: (2018)

Fecal Immunochemical Test and Fecal Calprotectin Results Show Different Profiles in Disease Monitoring for Ulcerative Colitis
por: Hiraoka, Sakiko, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_oni5u0pjh777cp83bfq49vomc6